UK flag as shield

Treatment  recommendation:

To treat moderate to severely active ulcerative colitis a final guidance was published recommending vedolizumab (Entyvio, Takeda)

Vedolizumab provides a further treatment option when conventional therapy or
TNF-alpha inhibitors either don’t work well, has stopped working or can’t be tolerated.

Vedolizumab is recommended on basis it is provided to the NHS at a reduced price. … more:


Leave a Comment

I accept the Privacy Policy

This site uses Akismet to reduce spam. Learn how your comment data is processed.